Qualigen launches Rosuvastatin to treat high cholesterol and to prevent cardiovascular disease
Qualigen launches Rosuvastatina 5 mg, 10 mg and 20 mg film-coated tablets EFG.
Rosuvastatina Qualigen EFG is bioequivalent to Crestor® and is indicated to treat high cholesterol and to prevent cardiovascular disease.
Rosuvastatine Qualigen is marketed in presentations of 28 tablets of 5 mg, 10 mg and 20 mg.
Rosuvastatine Qualigen requires a prescription for dispensing and is financed by the Spanish Health System with reduced contribution.
With this launch, Qualigen extends its product portfolio of drugs to prevent cardiovascular disease.